
Loading, please wait...

Loading, please wait...

The NEET-UG 2026 cancellation marks a significant turning point in the regulation of medical admissions in India. Consequently, the National Testing Agency (NTA) scrapped the examination conducted on May 3, 2026. This drastic measure emerged after investigators flagged serious concerns regarding the sanctity of the testing process. Furthermore, the Centre has officially handed the matter over to the Central Bureau of Investigation (CBI). This move seeks to address systemic vulnerabilities and restore public confidence in the national examination framework.
The NTA took the decision to cancel the test after reviewing critical inputs from various central agencies. Specifically, law enforcement findings suggested that the integrity of the examination process was compromised at multiple levels. Moreover, administrative glitches during the initial May session had already fueled frustration among students. For instance, power cuts in Indore and biometric errors caused significant delays. Therefore, the agency determined that the results from the May 3 session could not be upheld. This cancellation aims to ensure a fair and level playing field for all medical aspirants across the country.
The Central Government has mandated a comprehensive inquiry by the CBI to uncover the roots of the alleged malpractices. Additionally, the NTA has pledged full cooperation, offering all necessary records and assistance to the Bureau. This investigation will likely scrutinize the role of external intermediaries and potential security leaks within the testing centers. Similarly, the government is focusing on reforming the testing infrastructure to prevent future disruptions. Such steps are essential to protect the aspirations of over two million candidates who participate in this high-stakes exam annually.
Students who registered for the original May 2026 session do not need to submit a new application. Fortunately, their existing candidature data and chosen examination centers will remain valid for the upcoming re-test. The NTA will announce fresh dates and release revised admit cards through official channels shortly. Furthermore, the agency will not charge any additional examination fees for this process. Meanwhile, candidates are encouraged to continue their preparations and monitor the official NTA website for real-time updates regarding the examination schedule.
Q1: Why was the NEET-UG 2026 exam cancelled?
The NTA cancelled the exam due to serious concerns regarding its sanctity and integrity. Inputs from law enforcement agencies suggested that the examination process had been compromised, necessitating a full re-test to ensure fairness.
Q2: Do candidates need to pay fees again for the re-examination?
No, candidates do not need to pay any additional fees. The NTA stated that original registration details remain valid, and the re-test will be funded through the agency's internal resources.
Q3: Will the exam center change for the re-test?
The NTA intends to keep the chosen examination centers valid. However, candidates should verify their revised admit cards once they are released to confirm specific venue details and timings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


NTA cancels NEET-UG 2026 due to integrity concerns. The Centre orders a CBI probe while fresh dates for the medical entrance exam will be announced soon....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today